Retained Earnings - Ryvu Therapeutics SA (WSE:RVU) - Alpha Spread
R

Ryvu Therapeutics SA
WSE:RVU

Watchlist Manager
Ryvu Therapeutics SA
WSE:RVU
Watchlist
Price: 54.1 PLN -1.64% Market Closed
Market Cap: 1.3B PLN
Have any thoughts about
Ryvu Therapeutics SA?
Write Note

Ryvu Therapeutics SA
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ryvu Therapeutics SA
Retained Earnings Peer Comparison

Comparables:
I
IGN
M
MDB
S
SLV

Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
R
Ryvu Therapeutics SA
WSE:RVU
Retained Earnings
zł1.7m
CAGR 3-Years
-81%
CAGR 5-Years
-41%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Retained Earnings
zł2.2m
CAGR 3-Years
-35%
CAGR 5-Years
N/A
CAGR 10-Years
35%
M
Medicofarma Biotech SA
WSE:MDB
Retained Earnings
-zł3.1m
CAGR 3-Years
-33%
CAGR 5-Years
-114%
CAGR 10-Years
N/A
S
Selvita SA
WSE:SLV
Retained Earnings
zł211.9m
CAGR 3-Years
86%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ryvu Therapeutics SA's Retained Earnings?
Retained Earnings
1.7m PLN

Based on the financial report for Mar 31, 2024, Ryvu Therapeutics SA's Retained Earnings amounts to 1.7m PLN.

What is Ryvu Therapeutics SA's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
-41%

Over the last year, the Retained Earnings growth was -99%. The average annual Retained Earnings growth rates for Ryvu Therapeutics SA have been -81% over the past three years , -41% over the past five years .

Back to Top